Exhibition Floor Plan

Confirmed Exhibitors

3M Purification Stand B3
Aérial Stand E2-D8
AMYLGEN Stand E1 – D7
Artes Biotechnology Stand F2
ASF – Arvato Services France Stand C8
Association “Santakos slėnis” (Santaka Valley) Stand A1
Bionext Stand E2-D8
CEED Stand E2-D8
Cell&Co Stand A8
CIDETEC Nanomedicine Stand B6
Ciloa SAS Stand F1 – E4
CiToxLAB France – CiT SAS Stand E5
Confarma France Stand E2-D8
Cytena Stand E6
DELPHARM Biotech Stand B8
Domainex Stand A6
Erdyn Stand B4
Eurasanté Stand E1 – D7
FGK Clinical Research GmbH Stand A5
Findmed Stand D6
Future Worlds / University of Southampton Stand B10
Inoviem Scientific Stand A3
Kitos Biotech, srls Stand A7
Ksilink Stand E2-D8
Macopharma Stand D2
Magle Chemoswed AB Stand B5
Microsynth AG Stand B2
NHL Cluster Stand E1 – D7
OCR Stand D9
ProQinase GmbH Stand C2
RD-Biotech Stand F1 – E4
Science me Up Stand C10
SIMV Stand D5 – C13
SMALTIS Stand F1 – E4
Soladis Stand B7
Synaging SAS Stand C4
ViroScan3D Stand B1

    ARVATO Pays | Stand n°Stand C8

    Healthcare systems, sales channels and distribution chains undergo constant changes to ensure patients derive the greatest benefit from innovative and existing pharmaceuticals and medical products at the most reasonable costs. Arvato Healthcare develop tailor-made outsourcing solutions that actively include all stakeholders within the healthcare sector - from patients, doctors and pharmacists through to health insurance companies and manufacturers.


    Cell&Co BioServices Pays | Stand n°Stand A8

    Cell&Co BioServices offers a complete one-stop-shop solution for managing biological and clinical. The services we offer cover the following activities: • Biobanking; • GMP Biorepository; • Sample processing (extraction, aliquoting, fractionation, etc.) and bioanalysis; • Sampling kit design, production and supply; Cell&Co is certified ISO 9001 and NF S 96-900 and also applies the following quality standards GMP, GLP, GCP and BPR (Best Practices for Repositories).


    Centre européen d’étude du Diabète Pays | Stand n°E2-D8

    Created in 1991, the “Centre européen d’étude du Diabète” is a private translational diabetes research institute, encouraging active collaborations between clinicians and researchers, in order to develop innovative therapeutic strategies and therefor improve the patients’ daily life. From its original status, the structure is a strong partner in the Scientific European community and acquired a rich portfolio of national and international collaborations from both academic and non-academic sectors


    Confarma France Pays | Stand n°Stand E2-D8

    CONFARMA is an analytical service provider for pharmaceutical, biotechnology, medical device, chemical and cosmetic industries. CONFARMA go with you for your methods development, validations and routine analysis in microbiology, biology and physico-chemistry, according to the highest standards. The site is a pharmaceutical establishment authorized by ANSM and declared compliant with GMP and GLP principles. CONFARMA is ISO 9001, 14001, OHSAS 18001, ISO 17025 accredited by COFRAC and FDA.


    DELPHARM BIOTECH Pays | Stand n°B8

    You have identified reliable biomarkers or designed mAb against a bio-target. You have developed a companion diagnostic tool: immuno assay prototype (ELISA or LFIA) for biomarkers monitoring and you are willing to find a partner to industrialize your device before commercial batch. Delpharm Biotech, as Immuno Assay contract manufacturing organization (CMO) with all the capabilities, under ISO 13485 can meet your requirement in both veterinary and human diagnostic markets.


    Domainex Pays | Stand n°A6

    Domainex is an integrated drug discovery service company serving pharmaceutical, biotechnology, academic and patient foundations globally. Domainex provides highly efficient scientific solutions to enable successful drug discovery programmes against a wide range of targets. Our highly experienced molecular biologists, medicinal, computation and analytical chemists have a strong success record in drug discovery, delivering on average one candidate drug every year for the past six years.


    EURASANTÉ Pays | Stand n°E1 - D7

    Eurasanté is a development agency dedicated to tech transfer and business development in life sciences sector in Northern France region. Our experienced project managers help researchers, startups and companies with their development projects. To do so, Eurasante provides many services such as real estate, fundraising, recruitment and business development. It also promotes the Eurasante Bio-business Park, which already hosts 7 hospitals, 4 universities, 7 specialised schools and more than 160 companies. It benefits from an exceptional location at the heart of Europe.


    FGK Clinical Research GmbH Pays | Stand n°A5

    FGK Clinical Research GmbH is a Europe-based full service Contract Research Organization with offices in Germany (HQ), Poland, Czech Republic, Hungary and UK. We provide full service for Phase I - IV clinical studies. Our international client base includes biotechnology, medical device, and pharmaceutical companies. We have all the knowledge and experience necessary to guide you through the clinical trial process, from planning and approval to the final report.


    Kitos Biotech, srls Pays | Stand n°Stand A7

    Kitos Biotech provides cell-based assay services for anticancer drug discovery research, taking advantage of cutting-edge automation systems. Kitos Biotech is an italian private company founded in 2016 by two researchers in cancer cell and molecular biology. The laboratory is located in the scientific park of Porto Conte Ricerche (Italy).


    MACO PHARMA Pays | Stand n°D2

    Maco Pharma is one of the key players in the medical device industry for blood transfusion, solution bags and biotherapy. Their growth has always been driven by major innovations. These innovations are the result of substantial investments in research and development, as well as cooperation with customers and partners: blood centres, research laboratories, hospitals... For each of these 3 fields, Maco Pharma offers a range of products and services for each step of the processes. With 2300 employees, 4 plants (2 in France, 1 in Poland and 1 in Tunisia) and worldwide presence in nearly 100 countries, Maco Pharma aims at offering innovative solutions and quality products to optimise therapeutic practices and make them safer.



    The NHL Cluster is the only French cluster to combine Nutrition, Biotechnology and Health. The NHL Cluster focuses on the fields of prevention and treatment of life-style related diseases. We identify opportunities (technology, market, product, financial aid), we facilitate exchange between potential and existing members, we contribute to collaborative R&D projects between academia, national and international public research institutions and private companies. NHL Cluster, Your Innovation Partner.


    ProQinase Pays | Stand n°C2

    ProQinase is a preclinical CRO dedicated to support the development of cancer therapeutics by providing customized solutions that cover the full range of services from hit identification to preclinical testing. ProQinase’s portfolio includes biochemical kinase assays, cell-based assays, and in vivo tumor models. We continuously work to extend these services and, in addition, offers custom-tailored assay development to provide state-of-the-art drug discovery service.


    Santaka Valley Association Pays | Stand n°A1

    Association Santakos Slėnis (Santaka Valley) unites and integrates activities of 4 largest research and study institutions of Kaunas : Kaunas University of Technology, Lithuanian University of Health Sciences, Vytautas Magnus University and Lithuanian Energy Institute at the science and business valley "Santaka".The aim of association is to carry out interdiciplinary scientific and aplied research, to create proper conditions for high-quality research services to businesses, to coordinate.


    SynAging SAS Pays | Stand n°Stand C4

    SynAging focuses on disease-inducing misfolded protein aggregates. Advances in neurobiology helped to understand the pivotal role of soluble prion-like misfolded protein aggregates in neurodegenerative diseases. SynAging has proprietary procedures to create aggregates with highest reproducibility. Oligomers are used in vitro and in vivo to induce neurodegeneration acutely and provide drug developers with fast access to phenotypic models mimicking the corresponding neurodegenerative disease.